{
    "2020-01-03": [
        [
            {
                "time": "",
                "original_text": "康龙化成(03759.HK)：A股保荐代表变更为崔洪军",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "A股",
                        "保荐代表变更",
                        "崔洪军"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【增减持】康龙化成(03759.HK)获Wellington Management Group增持13.24万股",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "Wellington Management Group",
                        "增持",
                        "13.24万股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【权益变动】康龙化成(03759-HK)获WellingtonMgtGroup增持13.24万股",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "WellingtonMgtGroup",
                        "权益变动",
                        "增持",
                        "13.24万股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}